LOWENTHAL RICHARD E (President and CEO) sold 4.0% of their position (50K shares) of ARS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $724.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/22/2025ACC: 0001415889-25-022761
DirectorOfficer10% Owner· President and CEO
Since Nov 2022
-50K
Net shares
Net seller
$724.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
50K disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−50K
Price / share
$14.49
Trade value
$724.35K
% of position
4.0%
8/21/2025
1.25M→1.20M
Total
Net shares
−50K
Net value
-$724.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/21/2025 | S · Sale | −50K | $14.49 | $724.35K | 4.0% | 1.25M | 1.20M |
| Total | −50K | -$724.35K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned1.25M
Common Stock
IndirectShares owned8.86M
Total
10.11M indirect10.11M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.25M | Indirect |
| Common Stock | 8.86M | Indirect |
| Total | 10.11M | 10.11M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported